Desoximetasone

Quick links to important sections

Desoximetasone

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Desoximetasone

What is Desoximetasone? Defining the Corticosteroid Entity

Property Description
Active ingredient Desoximetasone (C22H29FO4)
Form Cream, gel, ointment, or solution (Topical administration)
Pharmacological class Topical Corticosteroid (Glucocorticoid)
Potency High-potency range
Origin Synthetic Fluorinated Steroid

Desoximetasone is a prescription-only medication classified as a topical corticosteroid intended for application to the skin. The active ingredient is the chemical entity Desoximetasone, identified by the molecular formula C22H29FO4. This compound is not natural; rather, it is a synthetic fluorinated steroid belonging to the broader glucocorticoid pharmacological class. The inclusion of fluorine in its chemical structure enhances its potency, positioning it within the high-potency range of topical steroids.


Classification and General Purpose

Desoximetasone functions as a single-ingredient medicine, formulated for topical administration in several dosage forms, including a cream, gel, ointment, and solution. These preparations use different dermatological bases to suit various skin areas and conditions. The fundamental purpose of this medication stems from its mechanism as a potent anti-inflammatory agent and antipruritic agent (anti-itching). Research confirms that this glucocorticoid action includes strong local vasoconstriction, contributing to its effectiveness in reducing swelling and redness. The key general benefit of Desoximetasone is to provide robust, localized relief from the intense inflammation, redness, and severe itching associated with various skin conditions.

What side effects are possible with Desoximetasone?

Possible Side Effects and Safety Information

The safety profile for the high-potency topical corticosteroid Desoximetasone is officially structured around two main categories: local skin reactions and potential serious systemic effects resulting from percutaneous absorption.

Adverse Reaction Scope

Category Details
System-organ classes involved Skin and Subcutaneous Tissue Disorders and Endocrine and Metabolic Disorders.
Common Reported Reactions Reactions such as burning, itching, irritation, dryness, folliculitis, and local skin changes like striae (stretch marks) and skin atrophy (thinning) are documented.
Serious Systemic Reactions Systemic absorption may lead to Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria, as noted in regulatory documents.

Contextual Safety Patterns

Official safety statements emphasize that the risk of both local and systemic adverse effects is directly related to exposure factors. Prolonged or long-term use, application over large surface areas, or the use of occlusive dressings are documented to increase the potential for adverse reactions.

Population-Specific Safety: Pediatric patients are noted to have greater susceptibility to systemic toxicity, including HPA axis suppression and associated effects such as linear growth retardation, due to their higher skin surface area-to-body weight ratio.

Safety Restrictions: Increased caution is advised for application to areas prone to greater absorption and local damage, such as the face, groin, or axillae (armpits). The medicine is contraindicated in individuals with known hypersensitivity to any component of the preparation.

Overdose and Emergency Response

Overdose: When to Seek Help

Desoximetasone is a potent topical corticosteroid. An overdose is primarily associated with the systemic absorption of the medicine through the skin, especially when used over large areas, for prolonged periods, or under occlusive dressings. Although it is applied to the skin, sufficient amounts can be absorbed into the body to cause systemic effects.

Documented Overdose Symptoms

The systemic effects observed in overdose are related to excess corticosteroid exposure. These include reversible hypothalamic-pituitary-adrenal (HPA) axis suppression and manifestations of Cushing’s syndrome. Other signs of systemic toxicity may include hyperglycemia (high blood sugar) and glucosuria (sugar in the urine). Pediatric patients are particularly susceptible to these systemic effects and may also show signs of intracranial hypertension, such as headaches or bulging fontanelles.

Emergency Actions

Immediate medical attention is required if an overdose is suspected, even if symptoms are not yet present. If the medicine is swallowed (ingested), contact a poison control center or a hospital emergency department right away. If the person has collapsed or is not breathing following ingestion, emergency services should be called immediately. Treatment for corticosteroid overdose is generally symptomatic and supportive, focusing on managing the resulting systemic imbalances.

Therapeutic Uses of Desoximetasone

What Desoximetasone Treats: Main Uses and Benefits

The primary role of Desoximetasone involves providing supportive relief for individuals managing various corticosteroid-responsive dermatoses. It is applied in addressing the inflammatory and pruritic manifestations of these conditions. This medication is commonly used to help with conditions characterized by periods of heightened symptoms, such as plaque psoriasis and eczema.

Addressing Severe Symptoms and Flare-ups

Desoximetasone is considered relevant for situations involving symptoms related to moderate to severe inflammatory states, which may include pronounced redness, swelling, and induration of the skin. It is also applied in addressing pruritic manifestations, helping to manage the severe, persistent itching that may be disruptive to daily functioning. This medication is applied during acute flare-ups of chronic inflammatory skin diseases when symptoms suddenly intensify, relevant when short-term symptomatic assistance is needed.

This supportive use contributes to easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable. The goal is supportive management:

“The medication may assist with managing the distressing intensity of the symptom cluster, supporting patients during episodes of heightened discomfort.”


Quick Fact: Support for Symptoms of Inflammation and Itching

Desoximetasone is commonly used when symptoms are related to both inflammatory and irritative states, contributing to improved day-to-day comfort.


Regulatory References

  1. DailyMed / NIH Label Information on Desoximetasone Cream

Eligibility and Restrictions for Use

Topical Desoximetasone is a prescription medication, and its use is strictly governed by regulatory documentation detailing eligible and restricted patient populations.

Populations Who Must Not Use Desoximetasone

Desoximetasone is contraindicated for any individual with a documented history of hypersensitivity or allergy to Desoximetasone or to any component of the specific cream, gel, ointment, or spray formulation.

Restrictions and Special Considerations

  • Pediatric Patients: Use in children is restricted due to a greater risk of systemic toxicity, including HPA axis suppression and Cushing’s syndrome, because of their larger skin surface area to body weight ratio. For some forms, safety and effectiveness have not been established in children under 10 years of age, and the topical spray is specifically not recommended for patients under 18 years.
  • Pregnancy and Lactation: As a Pregnancy Category C drug (older classification), it should be used only if the potential benefit to the mother justifies the potential risk to the fetus. It is recommended to use the smallest amount for the shortest duration. Caution is also advised during lactation.
  • Application Site: The medication must not be used on certain high-absorption areas, including the face, groin, or axilla (armpit). The topical spray form is also specifically prohibited for use on skin exhibiting atrophy (thinning) at the treatment site.
  • Underlying Health Conditions: Special caution and medical monitoring are required for patients with co-existing conditions such as liver failure, diabetes mellitus, or Cushing’s syndrome due to the potential for systemic absorption to unmask or worsen these conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for desoximetasone, a potent topical corticosteroid, focuses primarily on the risk of increased systemic exposure when co-administered with certain classes of medicinal products.

Documented Interaction Domains

Interaction Domain Practical Implication
Co-administered Corticosteroid Products Co-administration with other corticosteroid-containing medicines may lead to an additive increase in total systemic corticosteroid exposure. Regulatory guidelines restrict the use of multiple corticosteroid products concurrently without medical supervision.
CYP3A4 Inhibitors Drugs that inhibit the Cytochrome P450 3A4 (CYP3A4) enzyme (e.g., ritonavir, itraconazole) can inhibit the metabolism of corticosteroids. This inhibition may result in increased systemic drug concentrations and exposure. Clinical monitoring may be warranted when potent CYP3A4 inhibitors are co-administered.
Topical Anti-infective Agents When used concomitantly with topical anti-infectives, the corticosteroid component may mask the clinical signs of an underlying infection, such as bacterial, fungal, or viral conditions. It may also suppress hypersensitivity reactions to ingredients present in the anti-infective agent.

Regulatory Context

Formal drug-drug interaction studies have not been conducted with desoximetasone. The documented interaction profile is based on known pharmacological properties and reported effects of other corticosteroids, particularly concerning metabolic pathways and additive systemic effects. The clinical relevance of the interaction with CYP3A4 inhibitors is variable and depends on the dose and duration of the corticosteroid use and the potency of the inhibitor.

Mechanism of Action

Desoximetasone, a synthetic glucocorticoid, works by acting as an agonist for the Glucocorticoid Receptor (GR), a protein found in the cell's cytoplasm. The drug-receptor complex translocates to the cell nucleus, where it modulates gene transcription. This process actively represses the expression of genes encoding pro-inflammatory cytokines and chemokines, while upregulating anti-inflammatory proteins. This genomic action leads to the indirect inhibition of the enzyme Phospholipase A2 (PLA2), suppressing the synthesis of key inflammatory mediators, including prostaglandins and leukotrienes. Furthermore, the drug engages non-genomic mechanisms that cause local vasoconstriction, or the narrowing of small blood vessels, which reduces vascular permeability and decreases the efflux of fluid and immune cells into the tissue. The combined effect of modulated gene expression and vasoconstriction results in a reduction of localized fluid accumulation and alteration of cell proliferation patterns in the epidermis.

Dosage and Administration Information

Official Administration Guidelines

Desoximetasone, available as a cream, gel, ointment, and spray, is strictly for topical use (external application). The medication is not intended for oral, ophthalmic (eye), or intravaginal use.

Administration Scope

Category Official Instruction
Route of Administration Topical (External use only)
Dosing Schedule Apply a thin film to the affected skin areas twice daily (b.i.d.).
Preparation The topical spray is flammable; avoid heat, flames, or smoking during application.
Age-Group Rules Use in children should be limited to the least amount compatible with an effective regimen. Safety and effectiveness of the 0.25% ointment have not been established in patients below 10 years of age.
Special Conditions Do not use occlusive dressings (bandages) over the treated area unless directed by a physician.

Procedural and Duration Constraints

The standard procedure requires applying the thin film and rubbing it in gently. Application must be avoided on the face, axilla (underarm), and groin. Therapy should be discontinued promptly when control is achieved, and treatment beyond 4 weeks is generally not recommended for most formulations. If no improvement is observed within this time, the diagnosis and use should be re-evaluated. When used in the diaper area, parents should be advised against using tight-fitting diapers or plastic pants, as these act as occlusive dressings.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Desoximetasone

This section outlines the structure of the clinical research that has been conducted on Desoximetasone. The purpose is to describe the types of studies that exist, the populations they observed, and the boundaries of the available evidence, without providing clinical advice or making personal predictions.


Evidence for Use in Plaque Psoriasis

Research examined Desoximetasone for plaque psoriasis and was structured around short-term randomized controlled trials (RCTs). These studies were designed to examine symptom patterns and systemic markers when comparing the active drug against a non-medicated vehicle (placebo).

Researchers examined adults with confirmed diagnoses of moderate to severe plaque psoriasis. In these trials, studies monitored objective measures, such as investigator assessments of global disease status and outcomes capturing phases of heightened symptom activity, including scaling and redness. Research also monitored systemic markers, such as potential changes related to HPA axis suppression.

Findings describe patterns reported when comparing the active drug group to the vehicle group over the study period. What remains uncertain in this area is that the follow-up durations were typically limited (often 4 weeks) in the pivotal trials. Long-term outcomes for patients, or what happens to the symptoms after the initial study period, remain limited.

Evidence for Use in Other Inflammatory Skin Conditions

Research examined Desoximetasone for various corticosteroid-responsive dermatoses, which includes conditions such as eczema. The evidence base includes short-term RCTs and systematic reviews. Many of these trials were designed as comparative studies, where Desoximetasone was studied for its behavior when compared against other existing topical corticosteroids.

Research examined outcomes linked to inflammatory or irritative states, such as a reduction in pruritus (itching), scaling, and inflammation. Findings indicate patterns observed in patient-reported outcomes describing perceived discomfort and in investigator scores of symptoms. However, the evidence quality varies across studies, and the available data remain heterogeneous.

Evidence in Special Populations

Research examined Desoximetasone in pediatric populations (children 2 years of age and older), but these studies primarily monitored systemic markers, specifically HPA axis suppression. Data for certain groups, such as the elderly or patients with other co-existing medical conditions, remain insufficient in the published research, and findings related to these subgroups are uncertain.

What Is Still Uncertain About Desoximetasone Research

The short-term focus of the pivotal trials means that long-term effects are not fully established, especially regarding sustained systemic markers or the risk of long-term skin changes. Additionally, for the broad group of corticosteroid-responsive dermatoses, evidence quality varies across studies, and comparative evidence against every available treatment is lacking. Research continues to explore these areas to contribute to the broader evidence landscape.

Key Studies & References DESOXIMETASONE CREAM, U.S.P. - Official Drug Label Information

Frequently Asked Questions (FAQ)

Common questions about Desoximetasone (FAQ)


Q: Is Desoximetasone safe for use on children?

Official labeling describes that use in children is restricted to the least amount and shortest period compatible with an effective regimen. Children may be more susceptible to systemic side effects, such as HPA axis suppression, and require close monitoring by a healthcare provider.


Q: Is Desoximetasone considered an immunosuppressant?

Desoximetasone is officially classified as a synthetic corticosteroid with glucocorticoid activity. Its documented primary purpose is to act as a potent anti-inflammatory and anti-itch agent. Official product information focuses on these strong localized anti-inflammatory effects.


Q: What types of skin conditions specifically benefit from Desoximetasone?

This medicine is officially indicated for relieving the inflammatory and pruritic (itchy) symptoms associated with corticosteroid-responsive dermatoses. For example, the topical spray formulation is specifically indicated for the treatment of plaque psoriasis.


Q: Is there a maximum body area that Desoximetasone can be applied to?

Regulatory documents warn that applying the medication over large surface areas increases the risk of systemic side effects, such as HPA axis suppression. However, official labeling does not specify a numerical maximum percentage of body area that can be treated.


Q: Why does Desoximetasone require a prescription?

Desoximetasone is designated as a prescription-only medication because it is a high-potency topical corticosteroid. This classification is based on the need for medical supervision due to the potential for serious systemic adverse effects, like HPA axis suppression.


Q: What official warnings are associated with Desoximetasone use?

Key warnings include the potential for Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, a potential systemic effect. Other official warnings cite the risk of local skin reactions, such as skin thinning, and increased risk when used in children or under bandages (occlusive dressings).


Q: Why are official use conditions for Desoximetasone so specific?

The specific regulatory constraints, such as avoiding application to the face and limiting use to a short duration (e.g., four weeks), are constraints implemented to reduce the risk of systemic absorption. This careful approach helps mitigate potential serious side effects, particularly HPA axis suppression, due to the drug's high potency.


Q: Is Desoximetasone used for anything besides skin conditions?

Official documents state that this drug is approved and indicated strictly for topical application to the skin to treat inflammatory dermatoses. It is not approved for use orally, in the eyes (ophthalmic), or intravaginally.


Q: What happens if I stop using Desoximetasone suddenly?

Systemic absorption of the drug can potentially lead to HPA axis suppression, which means the body may produce less of certain stress hormones. Official information indicates the potential for temporary hormone insufficiency following withdrawal. The potential for this effect is the regulatory context for supervised discontinuation.


Q: What is the difference between the cream and the ointment forms of Desoximetasone?

The various forms of Desoximetasone, such as the cream and the ointment, utilize different inactive ingredients (bases) for application. For example, the ointment often uses a petrolatum base, while the cream uses an emollient base. Furthermore, some forms may have specific age restrictions noted in the regulatory documents.


Q: Do other countries use Desoximetasone for the same conditions as the US?

Regulatory documents from various global authorities generally indicate desoximetasone for the relief of corticosteroid-responsive skin conditions. Therefore, the officially approved uses of the drug in other countries are largely similar to the indications in the US.


Q: Are there generic versions of Desoximetasone available?

According to the FDA, generic versions of some Desoximetasone formulations are approved and available. The specific availability of a generic version may depend on the strength and the dosage form, such as cream, ointment, gel, or spray.


Q: What should I do if I miss an application of Desoximetasone?

Official patient information describes the procedure for a missed application, which involves applying it as soon as it is remembered unless it is near the next scheduled time, in which case the missed application is typically skipped. The advice includes never applying extra medication to compensate for a missed application.


Q: Can Desoximetasone cause changes in skin color or pigmentation?

Yes, local adverse reactions documented in official regulatory labeling can include changes in skin color or pigmentation. Specifically, hypopigmentation, which is the lightening of the treated skin area, is listed as a potential reaction.


Q: Is Desoximetasone addictive?

Desoximetasone is not classified as a controlled substance by the DEA. However, as a high-potency prescription drug, official information notes that its use carries risks of HPA axis suppression and potential rebound effects upon withdrawal.


Q: Is Desoximetasone known to cause acne breakouts?

Yes, official safety documents indicate that adverse reactions associated with the use of Desoximetasone can include acneiform eruptions (lesions resembling acne or pimples) and folliculitis (inflammation of hair follicles).


Q: Can Desoximetasone be used on cracked or broken skin?

Official patient guidance includes a caution against use on cuts, scrapes, or areas of damaged skin. This caution is advised because inflammation or broken skin can increase the amount of the high-potency corticosteroid absorbed systemically into the body.


Q: Is Desoximetasone a permanent fix for skin conditions?

The medication is indicated for the relief of symptoms such as inflammation and itching, not as a permanent cure for skin conditions. Official therapy guidelines recommend that use should be stopped promptly once the condition is controlled, confirming its role as a symptomatic treatment.


Q: How does Desoximetasone affect the skin barrier?

Regulatory warnings indicate that factors that increase the risk of systemic side effects include using the medication on an altered or damaged skin barrier. This suggests that broken or otherwise compromised skin can allow the drug to be more easily absorbed into the body.


Q: What ingredients are used to make Desoximetasone cream absorb into the skin?

The cream, gel, or ointment base contains various inactive ingredients, also called excipients, that help the medication absorb and apply correctly. These ingredients may include substances like isopropyl myristate, lanolin alcohol, or white petrolatum, depending on the specific formulation.


Q: Is the percentage strength of Desoximetasone important?

Yes, the percentage strength of the formulation is important because it correlates with the drug's potency. Official labeling notes that using more potent or higher-concentration steroids can increase the risk of HPA axis suppression and other systemic side effects.


Q: Can Desoximetasone make certain rashes worse?

The regulatory label notes that a failure of a skin condition to heal may indicate that a patient has developed allergic contact dermatitis to an ingredient in the topical steroid. If this occurs, the drug's use is typically discontinued.


Q: Is Desoximetasone ever used in combination with other topical ingredients?

Desoximetasone is officially supplied as a single-active-ingredient medicine, although the bases contain multiple inactive ingredients. Official documents advise against using other corticosteroid-containing products concurrently due to the risk of additive systemic exposure.

How should Desoximetasone be stored and disposed of?

How to Store and Dispose of Desoximetasone

Desoximetasone (cream, gel, and ointment) must be stored at a Controlled Room Temperature between 20°C to 25°C (68°F to 77°F) and protected from freezing and moisture. The product must be kept in a closed container and stored out of the reach of children.

The Desoximetasone topical spray must also be stored at room temperature, but is labeled as flammable and must be kept away from heat, flames, or smoking. The topical spray is subject to a stability constraint and must be discarded 30 days after being dispensed.

For disposal, unused or expired medication should be handled by consulting a healthcare professional and discarding the product according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Desoximetasone found in:

A-Z Index: